Related Experiment Video

Updated: May 15, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Anticoagulant therapy for ischemic stroke: A review of literature

Mohammad Mehdi Shahpouri1, Seyed Mousavi, Faribourz Khorvash

  • 1Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences
|December 26, 2012
PubMed

Insights

Anticoagulants for acute ischemic stroke lack strong evidence of effectiveness and safety, leading to ongoing expert debate. This review offers a framework for their emergent use despite controversial clinical data.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Anticoagulants are widely used for acute ischemic stroke to prevent recurrence, particularly in patients with atrial fibrillation or large-artery disease.
  • However, their efficacy and safety in this context remain controversial, with a lack of consensus among experts and practitioners.
  • Existing clinical data and reviews, including one by the American Heart Association, show no strong evidence supporting their effectiveness.

Purpose of the Study:

  • To review the current evidence regarding the emergent use of anticoagulants in acute ischemic stroke.
  • To provide a framework to guide the application of anticoagulants in managing acute ischemic stroke patients.

Main Methods:

  • Systematic review of existing literature and clinical trial data.
  • Analysis of expert opinions and survey results on anticoagulant use.
  • Evaluation of recommendations from professional bodies like the Stroke Council of the American Heart Association.

Main Results:

  • Definitive clinical data supporting the efficacy of emergent anticoagulation in acute ischemic stroke is lacking.
  • Several clinical trials indicate no significant improvement in patient outcomes with emergent anticoagulation.
  • There is a broad spectrum of expert opinions and a lack of consensus on optimal anticoagulant use.

Conclusions:

  • The effectiveness and safety of anticoagulants in acute ischemic stroke treatment are not definitively established.
  • Current evidence does not strongly support the routine emergent use of anticoagulants for improving clinical outcomes.
  • A structured framework is needed to navigate the uncertainties surrounding anticoagulant therapy in acute ischemic stroke.

Keywords:
AnticoagulantsIschemic StrokeSignificant effect

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...